How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Sell
38
OMRNY Quote, Financials, Valuation and Earnings
Last price:
$33.64
Seasonality move
:
-0.25%
Day range:
$33.38 - $33.64
52-week range:
$31.00 - $47.89
Dividend yield:
2%
P/E ratio:
105.40x
P/S ratio:
1.23x
P/B ratio:
1.24x
Volume:
42K
Avg. volume:
75.9K
1-year change:
-26.47%
Market cap:
$6.6B
Revenue:
$5.7B
EPS (TTM):
-$0.50
Analysts' Opinion
-
Consensus RatingOMRON has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, OMRON has an estimated downside of -- from its current price of $33.64.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $33.64.
Fair Value
-
According to the consensus of 0 analysts, OMRON has -- downside to fair value with a price target of -- per share.
OMRNY vs. S&P 500
-
Over the past 5 trading days, OMRON has overperformed the S&P 500 by 3.15% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
OMRON does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
OMRON revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter OMRON reported revenues of $1.2B.
Earnings Growth
-
OMRON earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter OMRON reported earnings per share of -$0.31.
Enterprise value:
7.7B
EV / Invested capital:
--
Price / LTM sales:
1.23x
EV / EBIT:
49.26x
EV / Revenue:
1.44x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-2,220.76x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
20.70x
Gross Profit (TTM):
$2.3B
Return On Assets:
-1.22%
Net Income Margin (TTM):
-1.84%
Return On Equity:
-1.69%
Return On Invested Capital:
-1.56%
Operating Margin:
3.84%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Income Statement | ||||||
| Revenue | $6.5B | $6.5B | $5.4B | $1.5B | $1.2B | |
| Gross Profit | $2.9B | $2.9B | $2.3B | $659.9M | $535.6M | |
| Operating Income | $620.4M | $767.5M | $157.2M | $135.3M | $45.3M | |
| EBITDA | $823.6M | $967M | $374M | $185.5M | $99.4M | |
| Diluted EPS | $2.12 | $2.92 | -$0.50 | $0.50 | -$0.31 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.2B | $4.9B | $3.4B | $3.3B | $3.7B | |
| Total Assets | $7.1B | $7.6B | $6.7B | $6.8B | $9.4B | |
| Current Liabilities | $1.3B | $1.4B | $1.4B | $1.3B | $1.7B | |
| Total Liabilities | $2B | $1.9B | $1.7B | $1.7B | $2.9B | |
| Total Equity | $5.2B | $5.7B | $5B | $5.1B | $6.5B | |
| Total Debt | -- | -- | -- | $8.1M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $600.6M | $395.9M | $311M | $252.3M | $95.3M | |
| Cash From Investing | -$1.3B | -$411.3M | -$742.2M | -$137.3M | -$206.5M | |
| Cash From Financing | -$263.7M | -$435.1M | $595.9M | -$32.1M | $143.8M | |
| Free Cash Flow | $303.5M | $62.5M | -$3.5M | $117.4M | -$10.8M | |
OMRNY
Sector
Market Cap
$6.6B
$122.9M
Price % of 52-Week High
70.24%
68.33%
Dividend Yield
2%
0%
Shareholder Yield
-0.75%
1%
1-Year Price Total Return
-26.47%
-6.91%
Beta (5-Year)
1.033
0.944
Dividend yield:
2%
Annualized payout:
$0.68
Payout ratio:
-68.41%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$32.75
200-day SMA
Sell
Level
$36.80
Bollinger Bands (100)
Sell
Level
33.85 - 42.99
Chaikin Money Flow
Buy
Level
363.3K
20-day SMA
Buy
Level
$32.66
Relative Strength Index (RSI14)
Buy
Level
50.65
ADX Line
Buy
Level
12.07
Williams %R
Neutral
Level
-43.9086
50-day SMA
Sell
Level
$35.51
MACD (12, 26)
Sell
Level
-0.56
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Neutral
Level
3.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.1658)
Buy
CA Score
(Annual)
Level (0.621)
Buy
Beneish M-Score
(Annual)
Level (-2.6586)
Buy
Momentum Score
Level (5)
Sell
Ohlson Score
Level (2.482)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Omron Corporation is an diversified industrials company, with businesses in the areas of industrial automation, healthcare, social systems, and electronic components. The industrial automation business offers automation control systems, motion/drives, sensors, and robotics. The social systems business provides automated ticket gates in train stations, ticket vending machines, as well as onboard driver monitoring service in mainly Japan. The company’s healthcare business offers blood pressure monitors, nebulizers, electrotherapy devices, thermometers, and others. The electronic/mechanical components business offers mainly switches, safety and control components, and relays. Omron was founded in 1933 and is headquartered in Kyoto, Japan.
Stock Forecast FAQ
In the current month, OMRNY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The OMRNY average analyst price target in the past 3 months is --.
-
Where Will OMRON Stock Be In 1 Year?
According to analysts, the consensus estimate is that OMRON share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About OMRON?
Analysts are divided on their view about OMRON share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that OMRON is a Sell and believe this share price will rise from its current level to --.
-
What Is OMRON's Price Target?
The price target for OMRON over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is OMRNY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for OMRON is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of OMRNY?
You can purchase shares of OMRON via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase OMRON shares.
-
What Is The OMRON Share Price Today?
OMRON was last trading at $33.64 per share. This represents the most recent stock quote for OMRON. Yesterday, OMRON closed at $33.64 per share.
-
How To Buy OMRON Stock Online?
In order to purchase OMRON stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is up 49.85% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 49.62% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is up 10.88% over the past day.
